GLP-1 analogues have completely changed this bleak therapeutic picture
Ethical statement and Biobank agreements Ethics committee of the hospital district of Uusimaa and Helsinki gave ethical approval for collection of the in-house control blood samples
A multidisciplinary lifestyle program for metabolic syndrome-associated osteoarthritis: the "plants for joints" randomized controlled trial
Tailored Solutions for GLP-1 RA Research for GLP-1 RA Research Whether you're studying weight loss efficacy, glycemic control, cardiovascular outcomes, or quality of life improvements, Signant Health's ePRO solutions deliver: Robust data collection for primary and secondary endpoints Expert input from our team of 50+ clinicians and COA scientists to drive highest quality evidence generation Evidence generation to support for health technology assessments and economic evaluations 24/7 global patient and site support Seamless integration of decentralized trial elements, such as eConsent, TeleVisits, and more
Restaurant-quality food delivered to your doorperfect portions, perfect macros, zero stress
An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats